金价，涨了！

Group 1 - The U.S. pharmaceutical company Eli Lilly has become the first pharmaceutical company globally to surpass a market capitalization of $1 trillion, driven by expanded production capacity and strong performance of its weight loss drugs [7] - Goldman Sachs predicts that Eli Lilly's oral version of its weight loss drug is expected to launch in the first quarter of next year, earlier than previously anticipated [7] - Eli Lilly has reached an agreement with the U.S. government to significantly reduce the prices of some weight loss drugs, which is expected to expand its market coverage and enhance sales growth potential [7] Group 2 - Concerns about overvaluation in the AI sector, combined with a decline in expectations for Federal Reserve interest rate cuts, have negatively impacted the performance of the U.S. stock indices, with the Dow Jones down 1.91%, S&P 500 down 1.95%, and Nasdaq down 2.74% [5] - The S&P Global report indicated that U.S. business activity expanded at the fastest pace in four months in November, with service sector growth accelerating and improved optimism about the economic outlook [1]